文献速递流行病学与生物统计临床试验与 GCP

临床试验多重比较中选择偏倚校正的统一贝叶斯框架

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials.
PubMed 文献 · Stat Med · 2024-05-14

临床试验中常因多种治疗、剂量、亚组或终点产生多重比较,易出现选择偏倚。本文提出一个统一的贝叶斯框架校正选择偏倚,无需事先指定先验的参数分布。模拟研究比较了多种方法,推荐使用基于高斯混合模型先验的贝叶斯模型平均估计量,并应用于一项多中心随机双盲安慰剂对照的度拉糖肽心血管效应研究。

要点

  • 提出统一贝叶斯框架校正临床试验多重比较中的选择偏倚,无需事先指定先验参数分布。
  • 模拟研究显示所比较方法优于正态收缩估计量,推荐基于高斯混合模型先验的贝叶斯模型平均估计量。
  • 该方法应用于一项多中心随机双盲安慰剂对照的度拉糖肽心血管效应研究。

核心结论

  • 所提出的统一贝叶斯框架可校正临床试验多重比较中的选择偏倚,且无需事先指定先验的参数分布。
  • 基于模拟研究性能与灵活性,推荐使用以高斯混合模型为先验分布的贝叶斯模型平均估计量。

研究设计与样本

  • 方法学文章,提出一个统一的贝叶斯框架以处理临床试验多重比较中的选择偏倚。
  • 通过模拟研究比较多种方法,并将方法应用于一项多中心、随机、双盲、安慰剂对照的度拉糖肽心血管效应研究。

主要发现

  • 模拟研究显示所比较方法优于正态收缩估计量。
  • 基于性能与灵活性,推荐以高斯混合模型为先验分布的贝叶斯模型平均估计量。
  • 该方法有助于通过校正选择偏倚更准确地解读临床试验结果。

关键数值与推荐

  • 选择偏倚定义为观察到的治疗效果与潜在真实值之间的偏差。
  • 推荐使用贝叶斯模型平均估计量,该估计量对高斯混合模型进行平均作为先验分布。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In clinical trials, multiple comparisons arising from various treatments/doses, subgroups, or endpoints are common. Typically, trial teams focus on the comparison showing the largest observed treatment effect, often involving a specific treatment pair and endpoint within a subgroup. These findings frequently lead to follow-up pivotal studies, many of which do not confirm the initial positive results. Selection bias occurs when the most promising treatment, subgroup, or endpoint is chosen for further development, potentially skewing subsequent investigations. Such bias can be defined as the deviation in the observed treatment effects from the underlying truth. In this article, we propose a general and unified Bayesian framework to address selection bias in clinical trials with multiple comparisons. Our approach does not require a priori specification of a parametric distribution for the prior, offering a more flexible and generalized solution. The proposed method facilitates a more accurate interpretation of clinical trial results by adjusting for such selection bias. Through simulation studies, we compared several methods and demonstrated their superior performance over the normal shrinkage estimator. We recommended the use of Bayesian Model Averaging estimator averaging over Gaussian Mixture Models as the prior distribution based on its performance and flexibility. We applied the method to a multicenter, randomized, double-blind, placebo-controlled study investigating the cardiovascular effects of dulaglutide.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Du Y, Li J, Raha S, et al. A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials. Stat Med. 2024. PMID: 38742595. doi:10.1002/sim.10064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。